---
title: "HUNDER NAOMI — Ownership Dossier"
canonical: https://whiteintel.dev/entity/efa5a662-0d8b-50dd-b07c-ee2edfb16cb3
json: https://whiteintel.dev/api/public/dossier/efa5a662-0d8b-50dd-b07c-ee2edfb16cb3
identifier: sec:0001832170
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HUNDER NAOMI

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001832170`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/efa5a662-0d8b-50dd-b07c-ee2edfb16cb3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/efa5a662-0d8b-50dd-b07c-ee2edfb16cb3  

## Ownership & control

### Holdings / subsidiaries

- **ARS Pharmaceuticals, Inc.** (officer) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HUNDER NAOMI**. Human view: https://whiteintel.dev/entity/efa5a662-0d8b-50dd-b07c-ee2edfb16cb3 · Structured JSON: https://whiteintel.dev/api/public/dossier/efa5a662-0d8b-50dd-b07c-ee2edfb16cb3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._